DOI: 10.1055/s-00000036

Laryngo-Rhino-Otologie

References

von Tresckow B, Morschhauser F, Ribrag V. et al.
An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1 R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma.

Clin Cancer Res 2015;
21: 1843-1850

Download Bibliographical Data

Search in:
Access: